Feed Preview

Fast Growing

Chronic Fatigue Syndrome

Chronic Fatigue Syndrome diagram by Nakatomi et al, Wikimedia
Nakatomi et al, Wikimedia

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Top 20 most recent papers
Scientific Reports

Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome

Scientific ReportsDecember 13, 2019
Alaa GhaliGeoffrey Urbanski
118
7
1
Acta Paediatrica

Myalgic Encephalomyelitis - Time to repent

Acta PaediatricaJanuary 23, 2020
Nigel Speight
3
bioRxiv

Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

bioRxivDecember 26, 2019
Ece KarhanDerya Unutmaz
332
7
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation

Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and RehabilitationJanuary 24, 2020
Natalie Eaton-FitchSonya Marshall-Gradisnik
13
2
Medicine

Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis

MedicineOctober 28, 2019
Maximillian J NelsonKade Davison
78
9
17
Medicine

Service based comparison of group cognitive behavior therapy to waiting list control for chronic fatigue syndrome with regard to symptom reduction and positive psychological dimensions

MedicineOctober 3, 2019
Adrian HealdAndreas Walther
26
7
The Journal of Clinical Investigation

Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations

The Journal of Clinical InvestigationDecember 13, 2019
Alexandra H MandaranoMaureen R Hanson
173
5
6
Sleep & Breathing = Schlaf & Atmung

Prevalence of self-reported sleep problems amongst adults with obstructive airway disease in the NHANES cohort in the United States

Sleep & Breathing = Schlaf & AtmungSeptember 15, 2019
Chitra LalCharlie Strange
Frontiers in Pharmacology

The Efficacy and Safety of Myelophil, an Ethanol Extract Mixture of Astragali Radix and Salviae Radix, for Chronic Fatigue Syndrome: A Randomized Clinical Trial

Frontiers in PharmacologySeptember 26, 2019
Jin-Yong JoungChang-Gue Son
1
1
8
1
NeuroImage. Clinical

Intra brainstem connectivity is impaired in chronic fatigue syndrome

NeuroImage. ClinicalNovember 1, 2019
Leighton R BarndenSandeep Bhuta
148
14
11
1
Brain, Behavior, and Immunity

Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome

Brain, Behavior, and ImmunityNovember 24, 2019
Akiko EguchiAriel E Feldstein
73
3
7
2
1
BMJ Open

Correction: Chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME) is different in children compared to in adults: a study of UK and Dutch clinical cohorts

BMJ OpenNovember 22, 2019
BMJ Open

Correction: unidentified chronic Fatigue Syndrome/myalgic encephalomyelitis (CFS/ME) is a major cause of school absence: surveillance outcomes from school-based clinics

BMJ OpenNovember 13, 2019
1
Clinical Psychology & Psychotherapy

CAN LINGUISTIC ANALYSIS BE USED TO IDENTIFY WHETHER ADOLESCENTS WITH A CHRONIC ILLNESS ARE DEPRESSED?

Clinical Psychology & PsychotherapyDecember 17, 2019
Lauren Stephanie JonesEsther Crawley
1
Frontiers in Medicine

The General Symptom Questionnaire-30 (GSQ-30): A Brief Measure of Multi-System Symptom Burden in Lyme Disease

Frontiers in MedicineDecember 24, 2019
Brian A FallonJohn N Aucott
21
1
Journal of Translational Medicine

Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome

Journal of Translational MedicineDecember 6, 2019
A MelvinLuis Nacul
40
4
1
Nutrients

Anti-Inflammatory Diets and Fatigue

NutrientsOctober 3, 2019
Ulrike HaßKristina Norman
1
PloS One

Myalgic encephalomyelitis/chronic fatigue Syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and treatment across European Union

PloS OneDecember 6, 2019
Elin B StrandEuropean Network on ME/CFS (EUROMENE)
36
3
BMC Neurology

A logistic regression analysis of risk factors in ME/CFS pathogenesis

BMC NeurologyNovember 9, 2019
Eliana LacerdaLuis Nacul
32
7
8
Oxidative Medicine and Cellular Longevity

Modification of Immunological Parameters, Oxidative Stress Markers, Mood Symptoms, and Well-Being Status in CFS Patients after Probiotic Intake: Observations from a Pilot Study

Oxidative Medicine and Cellular LongevityDecember 25, 2019
Letizia VenturiniChiara Cusa
8
6

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

© 2020 Meta ULC. All rights reserved
/feed-previews/chronic-fatigue-syndrome/68dbfb0f-e560-4919-bf8f-e99721cadd22